Cargando…
PI3KCA Mutations in Uterine Cervix Carcinoma
Background: Squamous cervical carcinoma represents an infection-associated malignancy that produces a high mortality when metastatic or recurrent after primary local treatment. There is an urgent need for new therapies for this cancer. Molecular lesions in cervical cancer may provide opportunities f...
Autor principal: | Voutsadakis, Ioannis A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7827547/ https://www.ncbi.nlm.nih.gov/pubmed/33435133 http://dx.doi.org/10.3390/jcm10020220 |
Ejemplares similares
-
Impact of KRAS, BRAF and PI3KCA mutations in rectal carcinomas treated with neoadjuvant radiochemotherapy and surgery
por: Derbel, Olfa, et al.
Publicado: (2013) -
MDM2 Amplification and PI3KCA Mutation in a Case of Sclerosing Rhabdomyosarcoma
por: Kikuchi, Ken, et al.
Publicado: (2013) -
Mass Screening for Carcinoma of the Uterine Cervix
por: Yule, R.
Publicado: (1975) -
Lymphoepithelioma-like carcinoma of the uterine cervix
por: Yun, Hyun Sil, et al.
Publicado: (2017) -
Invasive Micropapillary Carcinoma of the Uterine Cervix
por: Koh, Hyun Hee, et al.
Publicado: (2020)